Telemus Capital, LLC Becton Dickinson & CO Transaction History

Telemus Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$232.65 - $254.58 $202,405 - $221,484	-870 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$232.09 - $256.88 $13,925 - $15,412	60 Added 7.41%	870 $213,000
Q4 2020 Jan 28, 2021	BUY	$221.92 - $245.94 $179,755 - $199,211	810 New	810 $203,000
Q1 2020 Jun 05, 2020	SELL	$195.69 - $279.01 $156,552 - $223,208	-800 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$236.45 - $266.82 $8,985 - $10,139	-38 Reduced 4.53%	800 $218,000
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $193,226 - $214,595	838 New	838 $212,000
Q1 2018 Apr 27, 2018	SELL	$205.46 - $240.27 $66,979 - $78,328	-326 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$189.0 - $222.64 $61,614 - $72,580	326	326 $70,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.